These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1105549)

  • 1. Resolution of secondary hyperparathyroidism after cadaveric renal allograft.
    Varghese Z; Wills MR; Ahmed KY; Fairney A; Baillod RA; Tatler GL; Hopewell JP; Moorhead JF
    Proc Eur Dial Transplant Assoc; 1975; 11():261-7. PubMed ID: 1105549
    [No Abstract]   [Full Text] [Related]  

  • 2. [Methods of correcting hyperphosphatemia in chronic renal failure and in dialysis (review)].
    Novikov AI
    Ter Arkh; 1997; 69(12):63-7. PubMed ID: 9503540
    [No Abstract]   [Full Text] [Related]  

  • 3. Persistent hyperparathyroidism in renal transplant patients.
    Pabico RC; Ward HN; McKenna BA; Freeman RB
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():68-72. PubMed ID: 226952
    [No Abstract]   [Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary hyperparathyroidism and renal osteodystrophy in chronic renal failure. Analysis of 195 patients, with observations on the effects of chronic dialysis, kidney transplantation and subtotal parathyroidectomy.
    Katz AI; Hampers CL; Merrill JP
    Medicine (Baltimore); 1969 Sep; 48(5):333-74. PubMed ID: 4909606
    [No Abstract]   [Full Text] [Related]  

  • 6. Indications for parathyroidectomy in advanced renal disease.
    Buck BA; Robertson RD
    Surg Gynecol Obstet; 1971 Aug; 133(2):218-24. PubMed ID: 4935588
    [No Abstract]   [Full Text] [Related]  

  • 7. Secondary hyperparathyroidism in chronic renal failure.
    Malmaeus J
    Scand J Urol Nephrol Suppl; 1983; 70():1-63. PubMed ID: 6351238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Parathyroidectomy in secondary hyperparathyroidism in chronic uremic patients under dialysis treatment. Development of the surgical strategy].
    Zucchi C
    Minerva Med; 1985 Mar; 76(9-10):397-401. PubMed ID: 3982697
    [No Abstract]   [Full Text] [Related]  

  • 9. Secondary hyperparathyroidism in chronic renal failure. The clinical spectrum in uremia, during hemodialysis, and after renal transplantation.
    Massry SG; Coburn JW; Popovtzer MM; Shinaberger JH; Maxwell MH; Kleeman CR
    Arch Intern Med; 1969 Oct; 124(4):431-41. PubMed ID: 4901739
    [No Abstract]   [Full Text] [Related]  

  • 10. New developments in hyperphosphatemia management.
    Slatopolsky E
    J Am Soc Nephrol; 2003 Sep; 14(9 Suppl 4):S297-9. PubMed ID: 12939384
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hydroxyproline in the dialysate as a parameter of secondary hyperparathyroidism. Effects of phosphate reduction and alkalization].
    Schiessl JH; Schweigart U; Bottermann P; Kopp KF
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1310-3. PubMed ID: 25525
    [No Abstract]   [Full Text] [Related]  

  • 12. Japanese Society of Dialysis Therapy treatment guidelines for secondary hyperparathyroidism.
    Kazama JJ
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S44-7. PubMed ID: 17976085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caclium, phosphorus, and bone in renal disease and transplantation.
    Bricker NS; Slatopolsky E; Reiss E; Avioli LV
    Arch Intern Med; 1969 May; 123(5):543-53. PubMed ID: 4888973
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients.
    Guideline Working Group, Japanese Society for Dialysis Therapy
    Ther Apher Dial; 2008 Dec; 12(6):514-25. PubMed ID: 19140852
    [No Abstract]   [Full Text] [Related]  

  • 15. The need for better control of secondary hyperparathyroidism.
    Locatelli F
    Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V15-19. PubMed ID: 15284355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyproline excretion following renal transplantation: comparison with values found in primary hyperparathyroidism.
    Goulding A; McChesney R; Dixon SR
    N Z Med J; 1977 Jun; 85(590):517-21. PubMed ID: 343003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Parathyroidectomy and autotransplantation in renal hyperparathyroidism. I. Clinical and chemical laboratory studies following tissue selection].
    Niederle B; Hörandner H; Roka R; Woloszczuk W
    Chirurg; 1989 Oct; 60(10):665-70. PubMed ID: 2582874
    [No Abstract]   [Full Text] [Related]  

  • 18. Total parathyroidectomy and renal function in patients with chronic renal failure.
    Chan YL; Posen S; Savdie E; Caterson RJ; Mahony JF
    Miner Electrolyte Metab; 1983; 9(2):57-61. PubMed ID: 6687751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors of post renal transplant hyperparathyroidism.
    Hamidian Jahromi A; Roozbeh J; Raiss-Jalali GA; Dabaghmanesh A; Jalaeian H; Bahador A; Nikeghbalian S; Salehipour M; Salahi H; Malek-Hosseini A
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):573-6. PubMed ID: 19587496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of hyperparathyroidism associated with immunosuppressive therapy.
    Jassal SV; Bargman JM
    Clin Nephrol; 1998 Nov; 50(5):326-9. PubMed ID: 9840322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.